Institutional Manager · CIK 0001825034
Euclidean Capital LLC
NEW YORK, NY · File #028-20777
Latest AUM
$369.5M
Positions
12
Top-10 Concentration
99.8%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | VANGUARD INDEX FDS | 922908744 | +520,000 | +$99.3M | $0 |
| ADD | VANGUARD INTL EQUITY INDEX F | 922042775 | +411,900 | +$30.3M | +$5.6M |
| REDUCE | ALECTOR INC | ALEC | 0 | $0 | -$1.8M |
| REDUCE | FOGHORN THERAPEUTICS INC | FHTX | 0 | $0 | +$802,618 |
| REDUCE | ISHARES TR | 46429B598 | 0 | $0 | +$735,504 |
| REDUCE | ORIC PHARMACEUTICALS INC | ORIC | 0 | $0 | -$3.8M |
| REDUCE | PMV PHARMACEUTICALS INC | PMVP | 0 | $0 | -$394,146 |
| REDUCE | RAPT THERAPEUTICS INC | 75382E208 | 0 | $0 | +$664,451 |
| REDUCE | SPDR S&P 500 ETF TR | SPY | 0 | $0 | +$64,597 |
| REDUCE | SURROZEN INC | SRZNW | 0 | $0 | +$851,967 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202512 pos · $369.5M
- 13F HOLDINGS REPORTQ/E Sep 202511 pos · $238.0M
- 13F HOLDINGS REPORTQ/E Jun 202511 pos · $305.7M
- 13F HOLDINGS REPORTQ/E Mar 202511 pos · $266.1M
- 13F HOLDINGS REPORTQ/E Dec 202411 pos · $736.7M
- 13F HOLDINGS REPORTQ/E Sep 202412 pos · $906.8M
- 13F HOLDINGS REPORTQ/E Jun 202411 pos · $795.8M
- 13F HOLDINGS REPORTQ/E Mar 202413 pos · $780.0M
- 13F HOLDINGS REPORT (Amended)Q/E Dec 202313 pos · $458.4M
- 13F HOLDINGS REPORTQ/E Dec 202312 pos · $458.1M
Top 12 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | 922042775 | 2,990,084 | $220.0M | 59.53% |
| 2 | VANGUARD INDEX FDS | 922908744 | 520,000 | $99.3M | 26.88% |
| 3 | ISHARES TR | 46429B598 | 369,600 | $20.0M | 5.41% |
| 4 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $8.5M | 2.30% |
| 5 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $8.1M | 2.19% |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $3.3M | 0.89% |
| 7 | SPDR S&P 500 ETF TR | SPY | 4,104 | $2.8M | 0.76% |
| 8 | RAPT THERAPEUTICS INC | 75382E208 | 82,234 | $2.8M | 0.75% |
| 9 | ALECTOR INC | ALEC | 1,307,858 | $2.0M | 0.55% |
| 10 | SURROZEN INC | SRZNW | 87,696 | $2.0M | 0.54% |
| 11 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $722,674 | 0.20% |
| 12 | SURROZEN INC | SRZNW | 170,833 | $3,417 | 0.00% |